Join our Community
Support ToI and remove all ads
Learn more
×

cancer research

Illustrative image: cancer cells against a backdrop of DNA (Mohammed Haneefa Nizamudeen via iStock by Getty Images)
October 12, 2026, 4:15 pm
How cancer cells survive chemo: Israeli researchers find ‘guardian proteins’ protect tumors
Ben-Gurion University scientists show that destroying such proteins forces cancer cells to self-destruct, in potential key to overcoming chemotherapy resistance
By Diana Bletter
Illustration of Tel Aviv University's Prof. Yuval Ebenstein's new blood test, which uses a DNA chip to detect a tumor’s biological fingerprint. (Courtesy/Tel Aviv University)
September 7, 2026, 11:00 am
$60 Israeli blood test can detect stage 2-4 lung cancer with 93% accuracy, study shows
Tel Aviv University researchers develop simple chip that skips DNA sequencing; findings can pave the way for earlier cancer diagnostics and real-time treatment monitoring
By Diana Bletter
Winners of the 2026 ERC starting grants, from left to right, top row: Dr. Sharon Fleischer, Tel Aviv University, Dr. Leeat Keren, the Weizmann Institute of Science, Dr. Reuma Gadassi-Polack, Bar-Ilan University, Dr. Hagai Maron, the Technion-Israel Institute of Technology, Dr. Nir Hananya, the Technion-Israel Institute of Technology; bottom row, from left to right: Dr. Ran Finkelstein, Tel Aviv University, Dr Amit Vinograd, Tel Aviv University, Dr. Michael Chapman, Tel Aviv University, Dr. Or Zamir, Tel Aviv University, Dr. Arnold Filtser, Bar-Ilan University, Prof. Dean Doron of the Institute for the Theory of Computing in the Stein Faculty of Computer and Information Science at Ben-Gurion University of the Negev. (Photo of Keren, courtesy/Itai Belson; photo of Vinograd, courtesy/Yael Tzur; photo of Filtser, courtesy/Gabe Gomez; all other photos, courtesy)
September 3, 2026, 2:35 pm
Eleven Israeli researchers awarded prestigious EU starting grants
Tel Aviv University, Bar-Ilan University, Weizmann Institute, Ben-Gurion University of the Negev and Technion scholars to receive over $18 million in total European Research Council funds
By Diana Bletter
Dr. Ariel Afek, left, and doctoral student Noga Levy at Afek's lab at the Weizmann Institute of Science. (Courtesy/Weizmann Institute of Science)
August 26, 2026, 3:41 am
Breakthrough Israeli cancer study finds mutations break DNA when it doesn’t bend
Weizmann Institute of Science and Rowan University researchers show that repair enzymes fail to fix gene structures of certain shapes, in discovery that may lead to new therapies
By Diana Bletter
From left to right: Prof. Ayelet Erez of Weizmann Institute of Science, Dr. Yarden Ariav, a researcher in Erez’s lab, and Dr. Samah Hayek, senior epidemiologist at Clalit Health Services and a senior lecturer in Tel Aviv University's Department of Epidemiology and Preventive Medicine, School of Public Health. (Courtesy/Weizmann Institute of Science and Clalit Innovation)
August 3, 2026, 2:30 pm
In world first, Israeli scientists find active ingredient in Viagra may stop cancer spread
Researchers say mouse models and data from 5 million health fund members show erectile dysfunction drug and statins may improve outcomes by blocking cholesterol needed for cells to metastasize
By Diana Bletter
Asst. Prof. Assaf Zinger, left, of Technion-Israel Institute of Technology with PhD candidate Ofri Vizenblit in the Zinger lab. (Courtesy/Rami Shelush, Technion Spokesperson’s Office)
June 18, 2026, 5:05 pm
Israeli drug-free nanomedicine gives fresh hope in battling aggressive breast cancer
Technion scientists halt ‘triple-negative’ tumors in female mice models; particles made of materials already deemed safe for humans by international regulatory bodies
By Diana Bletter
Dr. Nachum Nathan, left, and Prof. Ziv Shulman of Weizmann Institute of Science. (Courtesy)
May 26, 2026, 6:02 pm
In a world first, Israeli scientists find ‘memory’ B cells can target ovarian tumors
Immune cells not only remember viruses, but can also secrete tumor-fighting antibodies, say Weizmann Institute researchers; study could further development of cancer vaccines
By Diana Bletter
Tslil Braun, PhD, Department of Molecular Genetics at Weizmann Institute of Science (left) with Prof. Eli Arama. Braun is holding a paintbrush used to observe the flies while they are anesthetized on the work surface. (Courtesy/Weizmann Institute of Science)
January 23, 2026, 9:06 am
Fruit fly study, almost wrecked by Iran, claims to uncover key to radiation-defying cells
Rescuing larvae from missile-damaged lab, Weizmann team finds cells that not only beat back death, but also multiply and spur regrowth, raising hopes for new therapies to keep cancer from recurring
By Diana Bletter
Laris Achlaug (left) and Lama Awwad, PhD students, work in a lab at the Technion-Israel Institute of Technology. (Courtesy/Nitzan Zohar)
December 26, 2025, 7:27 pm
In surprising breakthrough, scientists in Israel find cancer may help heal the failing heart
Study by researchers at the Technion finds that injecting cancerous serum in mice decreased cardiac fibrosis — paving the way for innovative therapies
By Diana Bletter
Prof. Ayal Hendel, Bar Ilan University. Goodman Faculty of LIfe(Courtesy/Avishag Shaar-Yashuv)
September 2, 2025, 10:48 am
Israeli researcher joins EU cell therapy initiative for blood cancers and tumors
Bar-Ilan University scientist part of €8 million consortium to ensure accuracy in CAR-T cell therapy, an immunotherapy using CRISPR-Cas9, in European hospitals
By Diana Bletter
Weizmann Institute's Prof. Zelig Eshhar holds a board that illustrates how the cancer treatment works with mice, August 29, 2017. (Shoshanna Solomon/Times of Israel)
July 4, 2025, 1:15 pm
Zelig Eshhar, leading cancer researcher and immunologist, dies at 84
Research by Weizmann Institute scientist and Israel Prize winner saved ‘countless lives,’ was basis for technology sold for $12 billion in 2017
By ToI Staff
Dr. Merav Cohen, center, of the Department of Clinical Microbiology and Immunology at the Gray Faculty of Medical & Health Sciences at Tel Aviv University, with Maya Levinson, left and Ori Moskowitz. (Courtesy/Tel Aviv University)
June 9, 2025, 4:49 pm
Israeli scientists discover immune cells that ‘both fight and fuel’ breast cancer
Tel Aviv University researchers say neutrophils can be late-stage breast cancer target and biomarker; Beilinson Hospital scientist uses immunotherapy to treat HER2-negative breast cancer
By Diana Bletter
Terri Swain-Collins uses a treadmill in the care of physiotherapist Alison MacDonald on May 20, 2025, at Kingston Injury Management, a clinic in Kingston, Ontario, in Canada. (Lisa Callahan via AP)
June 2, 2025, 4:53 am
Exercise boosts survival rates in colon cancer patients, study shows
Cancer centers and insurance plans should consider making exercise coaching a new standard of care for colon cancer survivors, say experts after study conducted in Israel and other countries
By Carla K. Johnson
Prof. Asaf Madi, left, Prof. Roded Sharan and PhD student Ron Sheinin of Tel Aviv University. (Courtesy/Tel Aviv University)
April 4, 2025, 8:57 am
Israeli researchers develop AI tool to discover how cells react to drug treatment
Tel Aviv University team’s scNET algorithm combines data on cells with protein ‘social network’ to cut ‘high noise’ and shed light on immune cell behavior
By Diana Bletter
Dr. Tomer Itkin of Tel Aviv University (Courtesy/Tel Aviv University)
March 30, 2025, 4:23 pm
In breakthrough, Israeli-led team activates dormant bone marrow cells for transplants
Using mRNA model made famous by COVID vaccine, researchers from Israel, US and Canada find protein to ‘awaken’ adult stem cells in mice; could significantly improve bone marrow transplant success rates
By Diana Bletter
Load More

Sign in or Join The Times of Israel Community

Sign in or Register

Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Sign in or Register
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.